Skip to main content
. 2018 Jan 30;10:187–202. doi: 10.2147/CLEP.S146757

Table S1.

Age-adjusted incidence rate ratios (95% CIs) for AKI during risk periods compared with baseline time in the main analysis and additional sensitivity analyses

Risk period Urinary tract infection Lower respiratory tract infection Gastroenteritis
Main analysis: AKI defined using N17 and N19 codes in any diagnostic position in any episode starting within 7 days of hospital admission; 60-day follow-up definitiona n=2,012 n=2,831 n=651
Baseline period Reference Reference Reference
Days after infection:
1–7 9.31 (7.76, 11.17) 6.03 (5.01, 7.25) 43.43 (34.00, 55.48)
8–14 4.09 (3.19, 5.23) 3.07 (2.42, 3.89) 7.37 (4.50, 12.05)
15–28 2.72 (2.18, 3.40) 1.90 (1.52, 2.36) 4.50 (2.85, 7.10)
ICD-10 N17 AKI: AKI defined using N17 codes only in any diagnostic position in any episode starting within 7 days of hospital admission; 60-day follow-up definitiona n=1,583 n=2,154 n=531
Baseline period Reference Reference Reference
Days after infection:
1–7 10.72 (8.79, 13.09) 6.84 (5.56, 8.41) 47.58 (36.32, 62.34)
8–14 4.85 (3.72, 6.33) 3.32 (2.53, 4.36) 8.65 (5.11, 14.64)
15–28 3.07 (2.40, 3.92) 2.05 (1.60, 2.64) 4.79 (2.87, 7.97)
Top diagnostic position: AKI defined using N17 and N19 codes recorded in the top two diagnostic positions in any episode starting within 7 days of hospital admission; 60-day follow-up definitiona n=891 n=1,086 n=288
Baseline period Reference Reference Reference
Days after infection:
1–7 10.42 (8.02, 13.53) 5.98 (4.42, 8.08) 62.81 (44.01, 89.65)
8–14 4.18 (2.89, 6.04) 3.18 (2.18, 4.65) 11.14 (5.62, 22.07)
15–28 2.95 (2.14, 4.07) 2.15 (1.53, 3.01) 7.75 (4.25, 14.13)
30-day follow-up: follow-up ends at the earliest of death, the end of registration, last collection date from GP, or 30 days after end of first break in the treatment of ≥30 days (main analysis uses 60 days) n=1,095 n=1,466 n=318
Baseline period Reference Reference Reference
Days after infection:
1–7 8.26 (6.53, 10.45) 7.28 (5.82, 9.12) 53.12 (38.31, 73.65)
8–14 3.59 (2.61, 4.94) 3.05 (2.23, 4.18) 12.49 (7.26, 21.48)
15–28 2.43 (1.82, 3.22) 2.17 (1.65, 2.86) 6.03 (3.45, 10.53)
90-day follow-up: follow-up ends at the earliest of death, the end of registration, last collection date from GP, or 90 days after end of first break in the treatment of ≥90 days (main analysis uses 60 days) n=2,444 n=3,468 n=805
Baseline period Reference Reference Reference
Days after infection:
1–7 9.04 (7.62, 10.72) 5.78 (4.85, 6.87) 43.08 (34.36, 54.00)
8–14 4.09 (3.26, 5.14) 2.95 (2.36, 3.68) 8.70 (5.69, 13.29)
15–28 2.66 (2.16, 3.26) 1.86 (1.52, 2.28) 4.48 (2.93, 6.84)
Calendar period: Adjusted for calendar period in addition to age;b main AKI definition; 60-day follow-up definitiona n=2,012 n=2,831 n=651
Baseline period Reference Reference Reference
Days after infection:
1–7 8.46 (7.05, 10.15) 5.59 (4.64, 6.73) 41.72 (32.52, 53.52)
8–14 3.71 (2.90, 4.75) 2.83 (2.23, 3.59) 7.06 (4.30, 11.58)
15–28 2.47 (1.98, 3.08) 1.73 (1.38, 2.15) 4.27 (2.70, 6.76)
Excluding early deaths: excludes all those who died within 60 days of AKI event; main AKI definition; 60-day follow-up definitiona n=1,542 n=1,965 n=516
Baseline period Reference Reference Reference
Days after infection:
1–7 9.05 (7.31, 11.21) 5.25 (4.15, 6.64) 50.14 (38.36, 65.52)
8–14 4.12 (3.09, 5.48) 2.50 (1.83, 3.41) 8.21 (4.77, 14.12)
15–28 2.50 (1.92, 3.26) 1.38 (1.02, 1.87) 4.50 (2.66, 7.61)

Notes:

a

Follow-up ends at the earliest of death, the end of registration, last collection date from GP, or 30/60/90 days after the end of first break in the treatment of 30/60/90 days or more. IRR denotes age-adjusted incidence ratio; age-adjusted in the following age bands: 18–44, 45–54, 55–59, 60–64, 65–69, 70–74, 75–84, 85–89, and 90+ years.

b

Adjusted for calendar time using the following periods: 1997–2000, 2001–2004, 2005–2008, 2009–2011, and 2012–2014.

Abbreviations: AKI, acute kidney injury; GP, general practitioner; ICD-10, International Classification of Diseases Version 10; IRR, incidence rate ratio.